+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Yiqing Keli Market - Global Forecast 2026-2032- Product Image
Yiqing Keli Market - Global Forecast 2026-2032- Product Image
Sale

Yiqing Keli Market - Global Forecast 2026-2032

  • Report

  • 188 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6128050
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Yiqing Keli Market is projected to reach USD 110.40 Million in 2026. It is expected to continue growing at a CAGR of 7.11%, reaching USD 165.28 Million by 2032.

Yiqing Keli: Executive Summary and Market Context

Yiqing Keli is a traditional Chinese medicine product associated with formulations used in respiratory and fever-related care. Its market context is shaped by consumer interest in herbal remedies, changing healthcare practices, regulatory requirements, and the need for credible evidence on quality, safety, and therapeutic use. Evaluation should distinguish traditional-use claims from clinically substantiated indications and account for differences in product classification across jurisdictions.

Regulation, Evidence, and Digital Access Are Reshaping the Landscape

The landscape is shifting toward stronger quality controls, traceable sourcing, standardized manufacturing, and clearer communication of intended use. Pharmacies, hospitals, specialist practitioners, e-commerce platforms, and direct-to-consumer channels increasingly influence product discovery and access. These shifts raise the importance of pharmacovigilance, authenticated distribution, transparent labeling, and clinical documentation while also creating opportunities for responsibly positioned traditional medicine products.

Artificial Intelligence Strengthens Quality, Discovery, and Patient Support

Artificial intelligence can support demand sensing, adverse-event monitoring, document review, supply-chain traceability, and personalized educational content. Natural-language systems may help organize traditional-use literature and identify evidence gaps, while computer vision can assist packaging authentication and manufacturing inspection. Human oversight remains essential because AI outputs cannot replace clinical judgment, regulatory review, validated quality testing, or informed consent.

Regional Insights: Adoption Depends on Healthcare Systems and Regulation

North America emphasizes regulatory compliance, practitioner oversight, product safety, and evidence communication. Latin America presents varied access conditions and regulatory frameworks, making distributor quality and Spanish- and Portuguese-language education important. Europe places strong emphasis on product classification, labeling, quality standards, and pharmacovigilance. Middle East markets require attention to import controls, healthcare-provider confidence, and culturally appropriate communication. Africa’s diverse health systems make affordability, dependable distribution, and responsible integration with professional care central considerations. Asia-Pacific combines established traditional-medicine ecosystems with rapidly expanding digital commerce, but requirements differ substantially by jurisdiction.

Group Insights: Economic and Security Blocs Shape Access and Standards

ASEAN requires navigation of diverse national rules, cross-border commerce practices, and multilingual consumer communication. BRICS markets offer varied traditional-medicine histories and healthcare structures, with local registration and manufacturing expectations remaining decisive. The European Union benefits from shared regulatory coordination while retaining country-level implementation considerations. G7 markets generally prioritize evidence quality, safety monitoring, and transparent claims. GCC markets place particular importance on import authorization, product authentication, and trusted clinical channels. NATO countries are not a single healthcare market, but their regulatory diversity and strong institutional procurement environments make compliance and professional engagement important.

Country Insights: Local Requirements Determine Commercial Readiness

Australia and Canada emphasize regulated therapeutic-product pathways, quality documentation, and practitioner or consumer safety. Brazil and Mexico require careful attention to national registration, labeling, and distribution controls. China has the deepest cultural and institutional familiarity with traditional Chinese medicine, but product positioning must align with applicable domestic standards. France, Germany, Italy, Spain, and the United Kingdom require market-specific compliance, evidence communication, and channel strategies. India combines strong interest in traditional medicine with distinct regulatory and clinical expectations. Japan and South Korea have sophisticated healthcare and consumer markets where quality, formulation consistency, and local approval pathways are critical. Russia presents heightened logistical, regulatory, and payment-compliance considerations. The United States places significant emphasis on truthful claims, manufacturing quality, adverse-event reporting, and clear separation between traditional-use information and disease-treatment assertions.

Action Priorities for Leaders: Build Trust Before Expanding Reach

Industry leaders should establish a jurisdiction-by-jurisdiction regulatory matrix before entering new channels, supported by validated manufacturing controls and auditable supplier qualification. They should invest in stability testing, contamination controls, packaging authentication, adverse-event systems, and clinical or observational evidence where appropriate. Education should clearly communicate intended use, contraindications, interactions, and when professional care is necessary. Digital growth should prioritize authorized sellers, responsible advertising, privacy protection, and AI tools with documented validation and human review. Partnerships with qualified practitioners, pharmacists, distributors, and research institutions can improve credibility and patient safety.

Research Methodology: Evidence-Based Interpretation Without Market Estimation

This executive summary uses the supplied product reference and applies a structured qualitative framework covering regulatory environment, healthcare delivery, distribution, consumer behavior, evidence standards, technology, and regional variation. Regional, group, and country observations are synthesized from established differences in healthcare governance and product-compliance expectations rather than from market estimates. Claims should be validated through current regulatory databases, official pharmacopoeias, peer-reviewed literature, product dossiers, safety reports, and interviews with qualified local experts before operational decisions are made.

Conclusion: Responsible Evidence and Compliance Define Sustainable Progress

Yiqing Keli’s outlook depends less on broad awareness than on demonstrable quality, appropriate claims, dependable supply, and integration with responsible healthcare practice. Differences across regions, economic groups, and countries make localized regulatory planning essential. Organizations that combine rigorous manufacturing, transparent evidence communication, professional engagement, and carefully governed digital tools will be better positioned to build durable trust while protecting patients and preserving the integrity of traditional medicine.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Yiqing Keli Market, by Product Formulation
7.1. Introduction
7.2. Standard Granule
7.2.1. Sugar-Coated Granule
7.2.2. Sugar-Free Granule
7.3. Pediatric Granule
7.3.1. Low-Dose Pediatric Granule
7.3.2. Standard Pediatric Granule
7.4. Capsule
7.4.1. Hard Capsule
7.4.2. Soft Capsule
7.5. Oral Solution
7.5.1. Ready-to-Drink Solution
7.5.2. Concentrated Solution
8. Yiqing Keli Market, by Dosage Strength
8.1. Introduction
8.2. Low Strength
8.3. Standard Strength
8.4. High Strength
8.5. Titrated Dose Packs
9. Yiqing Keli Market, by Indication Category
9.1. Introduction
9.2. Upper Respiratory Tract Infection
9.2.1. Common Cold
9.2.2. Acute Pharyngitis
9.2.3. Acute Tonsillitis
9.3. Influenza-Like Illness
9.3.1. Seasonal Influenza
9.3.2. Viral Fever
9.4. Lower Respiratory Complications
9.4.1. Acute Bronchitis
9.4.2. Exacerbation of Chronic Bronchitis
9.5. Preventive Use
9.5.1. Immunity Support
9.5.2. Post-Exposure Prophylaxis
10. Yiqing Keli Market, by End User
10.1. Introduction
10.2. Hospitals
10.3. Clinics
10.3.1. General Practitioner Clinics
10.3.2. ENT Clinics
10.3.3. TCM Clinics
10.4. Home Use
11. Yiqing Keli Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Retail Pharmacies
11.4. Traditional Medicine Clinics
11.5. Online Pharmacies
12. Yiqing Keli Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Yiqing Keli Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Yiqing Keli Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Anguo Yadong Biopharmaceutical Co., Ltd.
16.2. Guangdong Luofushan National Pharmaceutical Co., Ltd.
16.3. Guizhou Hengba Pharmaceutical Co., Ltd.
16.4. Jiangxi Huiren Pharmaceutical Co., Ltd.
16.5. Jiangxi Xinglin Baima Pharmaceutical Co., Ltd.
16.6. Jilin Gaomiao Pharmaceutical Co., Ltd.
16.7. Mengyang Pharmaceutical Co., Ltd.
16.8. Qionglai Tianyin Pharmaceutical Co., Ltd.
16.9. Shanxi Jinxin Shuanghe Pharmaceutical Co., Ltd.
16.10. Tonghua Hongbao Pharmaceutical Co., Ltd.
16.11. Tonghua Jinkaiwei Pharmaceutical Co., Ltd.
16.12. Tonghua Jinma Pharmaceutical Group Co., Ltd.
16.13. Yunnan Xitao Green Pharmaceutical Co., Ltd.
16.14. Zhejiang Weikang Pharmaceutical Co., Ltd.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Yiqing Keli Market, Years Considered for the Study
FIGURE 2. Global Yiqing Keli Market, Research Design
FIGURE 3. Global Yiqing Keli Market, Research Framework
FIGURE 4. Global Yiqing Keli Market, Data Triangulation
FIGURE 5. Global Yiqing Keli Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Yiqing Keli Market Size, by Product Formulation, 2025 vs 2032 (%)
FIGURE 7. Global Yiqing Keli Market Size, by Product Formulation, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Yiqing Keli Market Size, by Dosage Strength, 2025 vs 2032 (%)
FIGURE 9. Global Yiqing Keli Market Size, by Dosage Strength, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Yiqing Keli Market Size, by Indication Category, 2025 vs 2032 (%)
FIGURE 11. Global Yiqing Keli Market Size, by Indication Category, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Yiqing Keli Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Yiqing Keli Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Yiqing Keli Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Yiqing Keli Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Yiqing Keli Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Yiqing Keli Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Yiqing Keli Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Yiqing Keli Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Yiqing Keli Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Yiqing Keli Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Yiqing Keli Market Segmentation & Coverage
TABLE 2. Global Yiqing Keli Market Size, 2017-2032 (USD Million)
TABLE 3. Global Yiqing Keli Market Size, by Product Formulation, 2017-2032 (USD Million)
TABLE 4. Global Standard Granule Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Standard Granule Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Standard Granule Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Sugar-Coated Granule Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Sugar-Coated Granule Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Sugar-Coated Granule Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Sugar-Free Granule Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Sugar-Free Granule Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Sugar-Free Granule Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Pediatric Granule Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Pediatric Granule Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Pediatric Granule Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Low-Dose Pediatric Granule Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Low-Dose Pediatric Granule Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Low-Dose Pediatric Granule Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Standard Pediatric Granule Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Standard Pediatric Granule Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Standard Pediatric Granule Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Capsule Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Capsule Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Capsule Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Hard Capsule Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Hard Capsule Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Hard Capsule Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Soft Capsule Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Soft Capsule Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Soft Capsule Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Oral Solution Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Oral Solution Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Oral Solution Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Ready-to-Drink Solution Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Ready-to-Drink Solution Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Ready-to-Drink Solution Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Concentrated Solution Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Concentrated Solution Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Concentrated Solution Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Yiqing Keli Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 41. Global Low Strength Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Low Strength Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Low Strength Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Standard Strength Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Standard Strength Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Standard Strength Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global High Strength Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global High Strength Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global High Strength Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Titrated Dose Packs Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Titrated Dose Packs Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Titrated Dose Packs Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Yiqing Keli Market Size, by Indication Category, 2017-2032 (USD Million)
TABLE 54. Global Upper Respiratory Tract Infection Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Upper Respiratory Tract Infection Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Upper Respiratory Tract Infection Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Common Cold Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Common Cold Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Common Cold Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Acute Pharyngitis Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Acute Pharyngitis Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Acute Pharyngitis Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Acute Tonsillitis Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Acute Tonsillitis Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Acute Tonsillitis Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Influenza-Like Illness Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Influenza-Like Illness Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Influenza-Like Illness Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Seasonal Influenza Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Seasonal Influenza Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Seasonal Influenza Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Viral Fever Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Viral Fever Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Viral Fever Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Lower Respiratory Complications Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Lower Respiratory Complications Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Lower Respiratory Complications Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Acute Bronchitis Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Acute Bronchitis Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Acute Bronchitis Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Exacerbation of Chronic Bronchitis Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Exacerbation of Chronic Bronchitis Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Exacerbation of Chronic Bronchitis Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Preventive Use Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Preventive Use Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Preventive Use Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Immunity Support Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Immunity Support Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Immunity Support Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Post-Exposure Prophylaxis Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Post-Exposure Prophylaxis Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Post-Exposure Prophylaxis Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Yiqing Keli Market Size, by End User, 2017-2032 (USD Million)
TABLE 94. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global General Practitioner Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global General Practitioner Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global General Practitioner Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global ENT Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global ENT Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global ENT Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global TCM Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global TCM Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global TCM Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Home Use Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Home Use Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Home Use Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Yiqing Keli Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 113. Global Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Traditional Medicine Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Traditional Medicine Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Traditional Medicine Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Online Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Global Online Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. Global Online Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. Global Yiqing Keli Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Asia-Pacific Yiqing Keli Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Asia-Pacific Yiqing Keli Market Size, by Product Formulation, 2017-2032 (USD Million)
TABLE 128. Asia-Pacific Yiqing Keli Market Size, by Standard Granule, 2017-2032 (USD Million)
TABLE 129. Asia-Pacific Yiqing Keli Market Size, by Pediatric Granule, 2017-2032 (USD Million)
TABLE 130. Asia-Pacific Yiqing Keli Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 131. Asia-Pacific Yiqing Keli Market Size, by Oral Solution, 2017-2032 (USD Million)
TABLE 132. Asia-Pacific Yiqing Keli Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 133. Asia-Pacific Yiqing Keli Market Size, by Indication Category, 2017-2032 (USD Million)
TABLE 134. Asia-Pacific Yiqing Keli Market Size, by Upper Respiratory Tract Infection, 2017-2032 (USD Million)
TABLE 135. Asia-Pacific Yiqing Keli Market Size, by Influenza-Like Illness, 2017-2032 (USD Million)
TABLE 136. Asia-Pacific Yiqing Keli Market Size, by Lower Respiratory Complications, 2017-2032 (USD Million)
TABLE 137. Asia-Pacific Yiqing Keli Market Size, by Preventive Use, 2017-2032 (USD Million)
TABLE 138. Asia-Pacific Yiqing Keli Market Size, by End User, 2017-2032 (USD Million)
TABLE 139. Asia-Pacific Yiqing Keli Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 140. Asia-Pacific Yiqing Keli Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 141. North America Yiqing Keli Market Size, by Region, 2017-2032 (USD Million)
TABLE 142. North America Yiqing Keli Market Size, by Product Formulation, 2017-2032 (USD Million)
TABLE 143. North America Yiqing Keli Market Size, by Standard Granule, 2017-2032 (USD Million)
TABLE 144. North America Yiqing Keli Market Size, by Pediatric Granule, 2017-2032 (USD Million)
TABLE 145. North America Yiqing Keli Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 146. North America Yiqing Keli Market Size, by Oral Solution, 2017-2032 (USD Million)
TABLE 147. North America Yiqing Keli Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 148. North America Yiqing Keli Market Size, by Indication Category, 2017-2032 (USD Million)
TABLE 149. North America Yiqing Keli Market Size, by Upper Respiratory Tract Infection, 2017-2032 (USD Million)
TABLE 150. North America Yiqing Keli Market Size, by Influenza-Like Illness, 2017-2032 (USD Million)
TABLE 151. North America Yiqing Keli Market Size, by Lower Respiratory Complications, 2017-2032 (USD Million)
TABLE 152. North America Yiqing Keli Market Size, by Preventive Use, 2017-2032 (USD Million)
TABLE 153. North America Yiqing Keli Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. North America Yiqing Keli Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 155. North America Yiqing Keli Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 156. Latin America Yiqing Keli Market Size, by Region, 2017-2032 (USD Million)
TABLE 157. Latin America Yiqing Keli Market Size, by Product Formulation, 2017-2032 (USD Million)
TABLE 158. Latin America Yiqing Keli Market Size, by Standard Granule, 2017-2032 (USD Million)
TABLE 159. Latin America Yiqing Keli Market Size, by Pediatric Granule, 2017-2032 (USD Million)
TABLE 160. Latin America Yiqing Keli Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 161. Latin America Yiqing Keli Market Size, by Oral Solution, 2017-2032 (USD Million)
TABLE 162. Latin America Yiqing Keli Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 163. Latin America Yiqing Keli Market Size, by Indication Category, 2017-2032 (USD Million)
TABLE 164. Latin America Yiqing Keli Market Size, by Upper Respiratory Tract Infection, 2017-2032 (USD Million)
TABLE 165. Latin America Yiqing Keli Market Size, by Influenza-Like Illness, 2017-2032 (USD Million)
TABLE 166. Latin America Yiqing Keli Market Size, by Lower Respiratory Complications, 2017-2032 (USD Million)
TABLE 167. Latin America Yiqing Keli Market Size, by Preventive Use, 2017-2032 (USD Million)
TABLE 168. Latin America Yiqing Keli Market Size, by End User, 2017-2032 (USD Million)
TABLE 169. Latin America Yiqing Keli Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 170. Latin America Yiqing Keli Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 171. Europe Yiqing Keli Market Size, by Region, 2017-2032 (USD Million)
TABLE 172. Europe Yiqing Keli Market Size, by Product Formulation, 2017-2032 (USD Million)
TABLE 173. Europe Yiqing Keli Market Size, by Standard Granule, 2017-2032 (USD Million)
TABLE 174. Europe Yiqing Keli Market Size, by Pediatric Granule, 2017-2032 (USD Million)
TABLE 175. Europe Yiqing Keli Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 176. Europe Yiqing Keli Market Size, by Oral Solution, 2017-2032 (USD Million)
TABLE 177. Europe Yiqing Keli Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 178. Europe Yiqing Keli Market Size, by Indication Category, 2017-2032 (USD Million)
TABLE 179. Europe Yiqing Keli Market Size, by Upper Respiratory Tract Infection, 2017-2032 (USD Million)
TABLE 180. Europe Yiqing Keli Market Size, by Influenza-Like Illness, 2017-2032 (USD Million)
TABLE 181. Europe Yiqing Keli Market Size, by Lower Respiratory Complications, 2017-2032 (USD Million)
TABLE 182. Europe Yiqing Keli Market Size, by Preventive Use, 2017-2032 (USD Million)
TABLE 183. Europe Yiqing Keli Market Size, by End User, 2017-2032 (USD Million)
TABLE 184. Europe Yiqing Keli Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 185. Europe Yiqing Keli Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 186. Middle East Yiqing Keli Market Size, by Region, 2017-2032 (USD Million)
TABLE 187. Middle East Yiqing Keli Market Size, by Product Formulation, 2017-2032 (USD Million)
TABLE 188. Middle East Yiqing Keli Market Size, by Standard Granule, 2017-2032 (USD Million)
TABLE 189. Middle East Yiqing Keli Market Size, by Pediatric Granule, 2017-2032 (USD Million)
TABLE 190. Middle East Yiqing Keli Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 191. Middle East Yiqing Keli Market Size, by Oral Solution, 2017-2032 (USD Million)
TABLE 192. Middle East Yiqing Keli Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 193. Middle East Yiqing Keli Market Size, by Indication Category, 2017-2032 (USD Million)
TABLE 194. Middle East Yiqing Keli Market Size, by Upper Respiratory Tract Infection, 2017-2032 (USD Million)
TABLE 195. Middle East Yiqing Keli Market Size, by Influenza-Like Illness, 2017-2032 (USD Million)
TABLE 196. Middle East Yiqing Keli Market Size, by Lower Respiratory Complications, 2017-2032 (USD Million)
TABLE 197. Middle East Yiqing Keli Market Size, by Preventive Use, 2017-2032 (USD Million)
TABLE 198. Middle East Yiqing Keli Market Size, by End User, 2017-2032 (USD Million)
TABLE 199. Middle East Yiqing Keli Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 200. Middle East Yiqing Keli Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 201. Africa Yiqing Keli Market Size, by Region, 2017-2032 (USD Million)
TABLE 202. Africa Yiqing Keli Market Size, by Product Formulation, 2017-2032 (USD Million)
TABLE 203. Africa Yiqing Keli Market Size, by Standard Granule, 2017-2032 (USD Million)
TABLE 204. Africa Yiqing Keli Market Size, by Pediatric Granule, 2017-2032 (USD Million)
TABLE 205. Africa Yiqing Keli Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 206. Africa Yiqing Keli Market Size, by Oral Solution, 2017-2032 (USD Million)
TABLE 207. Africa Yiqing Keli Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 208. Africa Yiqing Keli Market Size, by Indication Category, 2017-2032 (USD Million)
TABLE 209. Africa Yiqing Keli Market Size, by Upper Respiratory Tract Infection, 2017-2032 (USD Million)
TABLE 210. Africa Yiqing Keli Market Size, by Influenza-Like Illness, 2017-2032 (USD Million)
TABLE 211. Africa Yiqing Keli Market Size, by Lower Respiratory Complications, 2017-2032 (USD Million)
TABLE 212. Africa Yiqing Keli Market Size, by Preventive Use, 2017-2032 (USD Million)
TABLE 213. Africa Yiqing Keli Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. Africa Yiqing Keli Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 215. Africa Yiqing Keli Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 216. Global Yiqing Keli Market Size, by Group, 2017-2032 (USD Million)
TABLE 217. ASEAN Yiqing Keli Market Size, by Group, 2017-2032 (USD Million)
TABLE 218. ASEAN Yiqing Keli Market Size, by Product Formulation, 2017-2032 (USD Million)
TABLE 219. ASEAN Yiqing Keli Market Size, by Standard Granule, 2017-2032 (USD Million)
TABLE 220. ASEAN Yiqing Keli Market Size, by Pediatric Granule, 2017-2032 (USD Million)
TABLE 221. ASEAN Yiqing Keli Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 222. ASEAN Yiqing Keli Market Size, by Oral Solution, 2017-2032 (USD Million)
TABLE 223. ASEAN Yiqing Keli Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 224. ASEAN Yiqing Keli Market Size, by Indication Category, 2017-2032 (USD Million)
TABLE 225. ASEAN Yiqing Keli Market Size, by Upper Respiratory Tract Infection, 2017-2032 (USD Million)
TABLE 226. ASEAN Yiqing Keli Market Size, by Influenza-Like Illness, 2017-2032 (USD Million)
TABLE 227. ASEAN Yiqing Keli Market Size, by Lower Respiratory Complications, 2017-2032 (USD Million)
TABLE 228. ASEAN Yiqing Keli Market Size, by Preventive Use, 2017-2032 (USD Million)
TABLE 229. ASEAN Yiqing Keli Market Size, by End User, 2017-2032 (USD Million)
TABLE 230. ASEAN Yiqing Keli Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 231. ASEAN Yiqing Keli Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 232. GCC Yiqing Keli Market Size, by Group, 2017-2032 (USD Million)
TABLE 233. GCC Yiqing Keli Market Size, by Product Formulation, 2017-2032 (USD Million)
TABLE 234. GCC Yiqing Keli Market Size, by Standard Granule, 2017-2032 (USD Million)
TABLE 235. GCC Yiqing Keli Market Size, by Pediatric Granule, 2017-2032 (USD Million)
TABLE 236. GCC Yiqing Keli Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 237. GCC Yiqing Keli Market Size, by Oral Solution, 2017-2032 (USD Million)
TABLE 238. GCC Yiqing Keli Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 239. GCC Yiqing Keli Market Size, by Indication Category, 2017-2032 (USD Million)
TABLE 240. GCC Yiqing Keli Market Size, by Upper Respiratory Tract Infection, 2017-2032 (USD Million)
TABLE 241. GCC Yiqing Keli Market Size, by Influenza-Like Illness, 2017-2032 (USD Million)
TABLE 242. GCC Yiqing Keli Market Size, by Lower Respiratory Complications, 2017-2032 (USD Million)
TABLE 243. GCC Yiqing Keli Market Size, by Preventive Use, 2017-2032 (USD Million)
TABLE 244. GCC Yiqing Keli Market Size, by End User, 2017-2032 (USD Million)
TABLE 245. GCC Yiqing Keli Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 246. GCC Yiqing Keli Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 247. European Union Yiqing Keli Market Size, by Group, 2017-2032 (USD Million)
TABLE 248. European Union Yiqing Keli Market Size, by Product Formulation, 2017-2032 (USD Million)
TABLE 249. European Union Yiqing Keli Market Size, by Standard Granule, 2017-2032 (USD Million)
TABLE 250. European Union Yiqing Keli Market Size, by Pediatric Granule, 2017-2032 (USD Million)
TABLE 251. European Union Yiqing Keli Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 252. European Union Yiqing Keli Market Size, by Oral Solution, 2017-2032 (USD Million)
TABLE 253. European Union Yiqing Keli Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 254. European Union Yiqing Keli Market Size, by Indication Category, 2017-2032 (USD Million)
TABLE 255. European Union Yiqing Keli Market Size, by Upper Respiratory Tract Infection, 2017-2032 (USD Million)
TABLE 256. European Union Yiqing Keli Market Size, by Influenza-Like Illness, 2017-2032 (USD Million)
TABLE 257. European Union Yiqing Keli Market Size, by Lower Respiratory Complications, 2017-2032 (USD Million)
TABLE 258. European Union Yiqing Keli Market Size, by Preventive Use, 2017-2032 (USD Million)
TABLE 259. European Union Yiqing Keli Market Size, by End User, 2017-2032 (USD Million)
TABLE 260. European Union Yiqing Keli Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 261. European Union Yiqing Keli Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 262. BRICS Yiqing Keli Market Size, by Group, 2017-2032 (USD Million)
TABLE 263. BRICS Yiqing Keli Market Size, by Product Formulation, 2017-2032 (USD Million)
TABLE 264. BRICS Yiqing Keli Market Size, by Standard Granule, 2017-2032 (USD Million)
TABLE 265. BRICS Yiqing Keli Market Size, by Pediatric Granule, 2017-2032 (USD Million)
TABLE 266. BRICS Yiqing Keli Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 267. BRICS Yiqing Keli Market Size, by Oral Solution, 2017-2032 (USD Million)
TABLE 268. BRICS Yiqing Keli Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 269. BRICS Yiqing Keli Market Size, by Indication Category, 2017-2032 (USD Million)
TABLE 270. BRICS Yiqing Keli Market Size, by Upper Respiratory Tract Infection, 2017-2032 (USD Million)
TABLE 271. BRICS Yiqing Keli Market Size, by Influenza-Like Illness, 2017-2032 (USD Million)
TABLE 272. BRICS Yiqing Keli Market Size, by Lower Respiratory Complications, 2017-2032 (USD Million)
TABLE 273. BRICS Yiqing Keli Market Size, by Preventive Use, 2017-2032 (USD Million)
TABLE 274. BRICS Yiqing Keli Market Size, by End User, 2017-2032 (USD Million)
TABLE 275. BRICS Yiqing Keli Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 276. BRICS Yiqing Keli Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 277. G7 Yiqing Keli Market Size, by Group, 2017-2032 (USD Million)
TABLE 278. G7 Yiqing Keli Market Size, by Product Formulation, 2017-2032 (USD Million)
TABLE 279. G7 Yiqing Keli Market Size, by Standard Granule, 2017-2032 (USD Million)
TABLE 280. G7 Yiqing Keli Market Size, by Pediatric Granule, 2017-2032 (USD Million)
TABLE 281. G7 Yiqing Keli Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 282. G7 Yiqing Keli Market Size, by Oral Solution, 2017-2032 (USD Million)
TABLE 283. G7 Yiqing Keli Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 284. G7 Yiqing Keli Market Size, by Indication Category, 2017-2032 (USD Million)
TABLE 285. G7 Yiqing Keli Market Size, by Upper Respiratory Tract Infection, 2017-2032 (USD Million)
TABLE 286. G7 Yiqing Keli Market Size, by Influenza-Like Illness, 2017-2032 (USD Million)
TABLE 287. G7 Yiqing Keli Market Size, by Lower Respiratory Complications, 2017-2032 (USD Million)
TABLE 288. G7 Yiqing Keli Market Size, by Preventive Use, 2017-2032 (USD Million)
TABLE 289. G7 Yiqing Keli Market Size, by End User, 2017-2032 (USD Million)
TABLE 290. G7 Yiqing Keli Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 291. G7 Yiqing Keli Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 292. NATO Yiqing Keli Market Size, by Group, 2017-2032 (USD Million)
TABLE 293. NATO Yiqing Keli Market Size, by Product Formulation, 2017-2032 (USD Million)
TABLE 294. NATO Yiqing Keli Market Size, by Standard Granule, 2017-2032 (USD Million)
TABLE 295. NATO Yiqing Keli Market Size, by Pediatric Granule, 2017-2032 (USD Million)
TABLE 296. NATO Yiqing Keli Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 297. NATO Yiqing Keli Market Size, by Oral Solution, 2017-2032 (USD Million)
TABLE 298. NATO Yiqing Keli Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 299. NATO Yiqing Keli Market Size, by Indication Category, 2017-2032 (USD Million)
TABLE 300. NATO Yiqing Keli Market Size, by Upper Respiratory Tract Infection, 2017-2032 (USD Million)
TABLE 301. NATO Yiqing Keli Market Size, by Influenza-Like Illness, 2017-2032 (USD Million)
TABLE 302. NATO Yiqing Keli Market Size, by Lower Respiratory Complications, 2017-2032 (USD Million)
TABLE 303. NATO Yiqing Keli Market Size, by Preventive Use, 2017-2032 (USD Million)
TABLE 304. NATO Yiqing Keli Market Size, by End User, 2017-2032 (USD Million)
TABLE 305. NATO Yiqing Keli Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 306. NATO Yiqing Keli Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 307. Global Yiqing Keli Market Size, by Country, 2017-2032 (USD Million)
TABLE 308. United States Yiqing Keli Market Size, 2017-2032 (USD Million)
TABLE 309. United States Yiqing Keli Market Size, by Product Formulation, 2017-2032 (USD Million)
TABLE 310. United States Yiqing Keli Market Size, by Standard Granule, 2017-2032 (USD Million)
TABLE 311. United States Yiqing Keli Market Size, by Pediatric Granule, 2017-2032 (USD Million)
TABLE 312. United States Yiqing Keli Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 313. United States Yiqing Keli Market Size, by Oral Solution, 2017-2032 (USD Million)
TABLE 314. United States Yiqing Keli Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 315. United States Yiqing Keli Market Size, by Indication Category, 2017-2032 (USD Million)
TABLE 316. United States Yiqing Keli Market Size, by Upper Respiratory Tract Infection, 2017-2032 (USD Million)
TABLE 317. United States Yiqing Keli Market Size, by Influenza-Like Illness, 2017-2032 (USD Million)
TABLE 318. United States Yiqing Keli Market Size, by Lower Respiratory Complications, 2017-2032 (USD Million)
TABLE 319. United States Yiqing Keli Market Size, by Preventive Use, 2017-2032 (USD Million)
TABLE 320. United States Yiqing Keli Market Size, by End User, 2017-2032 (USD Million)
TABLE 321. United States Yiqing Keli Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 322. United States Yiqing Keli Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 323. Canada Yiqing Keli Market Size, 2017-2032 (USD Million)
TABLE 324. Canada Yiqing Keli Market Size, by Product Formulation, 2017-2032 (USD Million)
TABLE 325. Canada Yiqing Keli Market Size, by Standard Granule, 2017-2032 (USD Million)
TABLE 326. Canada Yiqing Keli Market Size, by Pediatric Granule, 2017-2032 (USD Million)
TABLE 327. Canada Yiqing Keli Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 328. Canada Yiqing Keli Market Size, by Oral Solution, 2017-2032 (USD Million)
TABLE 329. Canada Yiqing Keli Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 330. Canada Yiqing Keli Market Size, by Indication Category, 2017-2032 (USD Million)
TABLE 331. Canada Yiqing Keli Market Size, by Upper Respiratory Tract Infection, 2017-2032 (USD Million)
TABLE 332. Canada Yiqing Keli Market Size, by Influenza-Like Illness, 2017-2032 (USD Million)
TABLE 333. Canada Yiqing Keli Market Size, by Lower Respiratory Complications, 2017-2032 (USD Million)
TABLE 334. Canada Yiqing Keli Market Size, by Preventive Use, 2017-2032 (USD Million)
TABLE 335. Canada Yiqing Keli Market Size, by End User, 2017-2032 (USD Million)
TABLE 336. Canada Yiqing Keli Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 337. Canada Yiqing Keli Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 338. Mexico Yiqing Keli Market Size, 2017-2032 (USD Million)
TABLE 339. Mexico Yiqing Keli Market Size, by Product Formulation, 2017-2032 (USD Million)
TABLE 340. Mexico Yiqing Keli Market Size, by Standard Granule, 2017-2032 (USD Million)
TABLE 341. Mexico Yiqing Keli Market Size, by Pediatric Granule, 2017-2032 (USD Million)
TABLE 342. Mexico Yiqing Keli Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 343. Mexico Yiqing Keli Market Size, by Oral Solution, 2017-2032 (USD Million)
TABLE 344. Mexico Yiqing Keli Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 345. Mexico Yiqing Keli Market Size, by Indication Category, 2017-2032 (USD Million)
TABLE 346. Mexico Yiqing Keli Market Size, by Upper Respiratory Tract Infection, 2017-2032 (USD Million)
TABLE 347. Mexico Yiqing Keli Market Size, by Influenza-Like Illness, 2017-2032 (USD Million)
TABLE 348. Mexico Yiqing Keli Market Size, by Lower Respiratory Complications, 2017-2032 (USD Million)
TABLE 349. Mexico Yiqing Keli Market Size, by Preventive Use, 2017-2032 (USD Million)
TABLE 350. Mexico Yiqing Keli Market Size, by End User, 2017-2032 (USD Million)
TABLE 351. Mexico Yiqing Keli Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 352. Mexico Yiqing Keli Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 353. Brazil Yiqing Keli Market Size, 2017-2032 (USD Million)
TABLE 354. Brazil Yiqing Keli Market Size, by Product Formulation, 2017-2032 (USD Million)
TABLE 355. Brazil Yiqing Keli Market Size, by Standard Granule, 2017-2032 (USD Million)
TABLE 356. Brazil Yiqing Keli Market Size, by Pediatric Granule, 2017-2032 (USD Million)
TABLE 357. Brazil Yiqing Keli Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 358. Brazil Yiqing Keli Market Size, by Oral Solution, 2017-2032 (USD Million)
TABLE 359. Brazil Yiqing Keli Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 360. Brazil Yiqing Keli Market Size, by Indication Category, 2017-2032 (USD Million)
TABLE 361. Brazil Yiqing Keli Market Size, by Upper Respiratory Tract Infection, 2017-2032 (USD Million)
TABLE 362. Brazil Yiqing Keli Market Size, by Influenza-Like Illness, 2017-2032 (USD Million)
TABLE 363. Brazil Yiqing Keli Market Size, by Lower Respiratory Complications, 2017-2032 (USD Million)
TABLE 364. Brazil Yiqing Keli Market Size, by Preventive Use, 2017-2032 (USD Million)
TABLE 365. Brazil Yiqing Keli Market Size, by End User, 2017-2032 (USD Million)
TABLE 366. Brazil Yiqing Keli Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 367. Brazil Yiqing Keli Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 368. United Kingdom Yiqing Keli Market Size, 2017-2032 (USD Million)
TABLE 369. United Kingdom Yiqing Keli Market Size, by Product Formulation, 2017-2032 (USD Million)
TABLE 370. United Kingdom Yiqing Keli Market Size, by Standard Granule, 2017-2032 (USD Million)
TABLE 371. United Kingdom Yiqing Keli Market Size, by Pediatric Granule, 2017-2032 (USD Million)
TABLE 372. United Kingdom Yiqing Keli Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 373. United Kingdom Yiqing Keli Market Size, by Oral Solution, 2017-2032 (USD

Companies Mentioned

  • Anguo Yadong Biopharmaceutical Co., Ltd.
  • Guangdong Luofushan National Pharmaceutical Co., Ltd.
  • Guizhou Hengba Pharmaceutical Co., Ltd.
  • Jiangxi Huiren Pharmaceutical Co., Ltd.
  • Jiangxi Xinglin Baima Pharmaceutical Co., Ltd.
  • Jilin Gaomiao Pharmaceutical Co., Ltd.
  • Mengyang Pharmaceutical Co., Ltd.
  • Qionglai Tianyin Pharmaceutical Co., Ltd.
  • Shanxi Jinxin Shuanghe Pharmaceutical Co., Ltd.
  • Tonghua Hongbao Pharmaceutical Co., Ltd.
  • Tonghua Jinkaiwei Pharmaceutical Co., Ltd.
  • Tonghua Jinma Pharmaceutical Group Co., Ltd.
  • Yunnan Xitao Green Pharmaceutical Co., Ltd.
  • Zhejiang Weikang Pharmaceutical Co., Ltd.

Related Topics

Related Reports

Qinghouyan Granules Market - Global Forecast 2026-2032 - Product Image

Qinghouyan Granules Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Wei Kang Ling Granules Market - Global Forecast 2026-2032 - Product Image

Wei Kang Ling Granules Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Homeopathy Medicine Treatment - Global Strategic Business Report - Product Image

Homeopathy Medicine Treatment - Global Strategic Business Report

  • Report
  • 481 Pages
  • Global
From
Vitamin D Therapy - Global Strategic Business Report - Product Image

Vitamin D Therapy - Global Strategic Business Report

  • Report
  • 222 Pages
  • Global
From
Herbal Supplements Market Size, Share, Trends and Forecast by Product Type, Formulation, Consumer, and Region, 2026-2034 - Product Image

Herbal Supplements Market Size, Share, Trends and Forecast by Product Type, Formulation, Consumer, and Region, 2026-2034

  • Report
  • 147 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.